Engflag

Cefoperazone/sulbactam

Quick links to important sections

Cefoperazone/sulbactam

Cefoperazone_sulbactam_EN

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cefoperazone/sulbactam

What is Cefoperazone/sulbactam?

Cefoperazone/sulbactam is a combination medicine consisting of two distinct components: cefoperazone, a third-generation cephalosporin antibiotic, and sulbactam, a beta-lactamase inhibitor. This combination is designed to treat various bacterial infections by addressing the mechanisms that some bacteria use to resist antibiotic treatment.

How the Combination Works

The two components of this medication work together through complementary mechanisms:

  • Cefoperazone: This is the primary antibacterial agent. It works by interfering with the synthesis of the bacterial cell wall. By preventing bacteria from forming a stable outer structure, it causes the bacterial cells to rupture and die.
  • Sulbactam: While sulbactam has limited antibacterial activity when used alone, its primary role is to protect the cefoperazone. Many resistant bacteria produce enzymes called beta-lactamases that can break down and deactivate cephalosporin antibiotics. Sulbactam attaches to these enzymes and neutralizes them, allowing cefoperazone to remain effective against these otherwise resistant strains.

Spectrum of Activity

Because of the synergistic effect of its components, cefoperazone/sulbactam is effective against a broad range of microorganisms, including:

  • Gram-negative bacteria: Including various species often found in hospital-acquired infections.
  • Gram-positive bacteria: Including certain strains of staphylococci and streptococci.
  • Anaerobic bacteria: Microorganisms that grow in environments without oxygen.

Common Applications

This combination is typically used for the treatment of moderate to severe infections where resistance is suspected or where multiple types of bacteria may be present. Common areas of application include:

  • Respiratory tract infections
  • Urinary tract infections
  • Intra-abdominal infections
  • Skin and soft tissue infections
  • Bacterial infections of the blood (sepsis)

Regulatory References

  1. NLM Overview of Beta-Lactamase Inhibitors

What side effects are possible with Cefoperazone/sulbactam?

Possible side effects and safety information

Cefoperazone/sulbactam is associated with a range of possible adverse reactions that are officially classified by their reported frequency in regulatory documents. These effects are grouped according to the physiological system or organ they involve.

Frequency-Classified Adverse Reactions

The most commonly reported reactions are generally categorized as common and include diarrhea, eosinophilia (an increase in a type of white blood cell), and transient elevations in liver enzymes. Effects classified as uncommon include headache, drug fever, and local reactions such as pain or phlebitis at the injection site.

Serious Adverse Reactions

The medicine's regulatory profile highlights several serious, though rare, adverse reactions. These include potentially fatal hypersensitivity reactions (anaphylaxis) and severe skin reactions such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Other serious events include cases of haemorrhage (bleeding) and Clostridium difficile-associated diarrhea (CDAD), which may range from mild to life-threatening.

Safety Constraints and Specific Population Notes

Official labeling includes constraints for specific populations. Dose adjustment or close monitoring may be necessary for individuals with severe hepatic disease, biliary obstruction, or marked decrease in renal function. The medicine is contraindicated in patients with a known history of allergy to the active ingredients, other cephalosporins, or penicillins. Furthermore, a high-level safety note states that a disulfiram-like reaction (flushing, headache) may occur if alcohol is consumed during or up to five days after treatment.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes overdose with Cefoperazone/sulbactam as a risk for specific Central Nervous System (CNS) toxicity. This risk is primarily linked to excessive concentrations of the cefoperazone component reaching the cerebrospinal fluid.

Overdose Symptoms and Risks:

Overdose Domain Clinical Manifestation
CNS Toxicity Seizures (convulsions)
Population Risk Patients with impaired renal function

In cases of suspected overdose, the most significant officially documented clinical manifestation is the occurrence of seizures or convulsions. This severe neurological event is more likely to occur in patients who have impaired kidney function, as the reduced clearance can lead to higher-than-intended drug levels in the body, increasing the potential for CNS exposure.

Required Emergency Action

Immediate medical help must be sought if any symptoms of overdose, particularly a seizure or convulsion, are observed. Regulatory guidance indicates that there is no specific antidote for overdose. However, since both cefoperazone and sulbactam components are substantially removed from the body by hemodialysis, this procedure may be employed in the management of an overdose, especially for patients who have impaired renal function. The immediate goal is to stop the drug's administration and manage the neurological symptoms under emergency medical supervision.

Therapeutic Uses of Cefoperazone/sulbactam

What Cefoperazone/sulbactam treats: main uses and benefits

Cefoperazone/sulbactam is a combination antibacterial medication used to treat a wide variety of bacterial infections. It belongs to a class of medications known as beta-lactamase inhibitor combinations, which pair a cephalosporin antibiotic with a protective agent to enhance effectiveness against resistant bacteria.

Therapeutic Applications

This medication is primarily used for moderate to severe infections where multiple types of bacteria may be present or where resistance to standard antibiotics is suspected. Common applications include:

  • Respiratory Tract Infections: Treatment of severe pneumonia, lung abscesses, and chronic bronchitis exacerbations caused by susceptible organisms.
  • Abdominal Infections: Management of peritonitis, cholecystitis, cholangitis, and other intra-abdominal infections.
  • Urinary Tract Infections: Addressing complicated infections of the kidneys or bladder.
  • Skin and Soft Tissue Infections: Treatment of cellulitis, wound infections, and diabetic foot infections.
  • Systemic Infections: Management of bacterial septicemia (bloodstream infections) and meningitis.
  • Gynecological Infections: Treatment of pelvic inflammatory disease and endometritis.

Mechanism and Benefits

The primary benefit of combining cefoperazone with sulbactam is the expanded spectrum of activity against bacteria that produce beta-lactamase enzymes. These enzymes are a common defense mechanism used by bacteria to deactivate antibiotics.

  • Cefoperazone works by interfering with the synthesis of the bacterial cell wall, leading to the eventual destruction of the bacteria.
  • Sulbactam acts as a beta-lactamase inhibitor. While it has little antibacterial activity on its own, it binds to and neutralizes the enzymes that would otherwise destroy cefoperazone.

By protecting the antibiotic from enzymatic degradation, this combination allows for the effective treatment of infections caused by aerobic, anaerobic, gram-positive, and gram-negative bacteria that might be resistant to cefoperazone alone. This broad-spectrum coverage is particularly beneficial in hospital settings and for patients with complex, mixed infections.

Eligibility and Restrictions for Use

Cefoperazone/sulbactam is an injectable combination antibiotic used to treat various bacterial infections. Its use is determined by the patient's specific health profile and medical history.

Who Can Use Cefoperazone/sulbactam?

Generally, this medication is indicated for patients with serious bacterial infections, including those affecting the respiratory tract, abdomen, urinary tract, and skin and soft tissues, where the infection is caused by susceptible organisms. It is frequently used in a hospital setting for moderate to severe infections. The dosage may need adjustment for patients with significant renal or hepatic impairment.

Who Should NOT Use Cefoperazone/sulbactam?

The primary contraindication is a known hypersensitivity or severe allergic reaction to cefoperazone, sulbactam, or any other beta-lactam antibiotics, such as penicillins or other cephalosporins.

Caution is also advised for patients with a history of gastrointestinal disease, particularly colitis. The drug should be used carefully in patients with pre-existing bleeding disorders or those taking anticoagulant medications, due to the cefoperazone component's potential to affect vitamin K-dependent clotting factors.

What should I know about interactions with other medicines?

Cefoperazone/sulbactam Interactions with Other Medicines and Products

This section outlines the clinically relevant and physicochemical interactions for Cefoperazone/sulbactam as documented in official government regulatory sources.

Documented Pharmacodynamic and Procedural Interactions

Interaction Type Interacting Substance Official Constraint and Risk
Pharmacodynamic Risk Alcohol (Ethanol) Patients must avoid alcohol during treatment and for up to five days afterward due to the risk of a Disulfiram-like reaction (flushing, headache, tachycardia).
Coagulation Risk Oral Anticoagulants Co-administration increases the risk of hypoprothrombinemia and bleeding due to the antibiotic's potential to reduce intestinal Vitamin K synthesis.
Physicochemical Incompatibility Aminoglycosides Solutions must not be mixed directly in the same intravenous line due to physical incompatibility which can lead to inactivation.
Preparation Incompatibility Lactated Ringer's Solution This solution must not be used for the initial reconstitution of the powder due to documented incompatibility.

Population-Specific Interaction Notes

Patients with severe hepatic disease or biliary obstruction may experience a prolonged half-life of Cefoperazone, which can increase the overall relevance of interactions, such as the bleeding risk with oral anticoagulants. Individuals with underlying risks for Vitamin K deficiency (e.g., poor nutrition) are also more susceptible to this coagulopathy risk. No specific pharmacokinetic interactions, such as those involving CYP enzymes or drug transporters, are formally documented in the official prescribing information.

Mechanism of Action

Direct Covalent Inhibition of Bacterial Cell Wall Synthesis

The antibiotic component, Cefoperazone, acts by directly and irreversibly binding to Penicillin-Binding Proteins (PBPs) within the bacterial membrane. These transpeptidase enzymes are vital for the final step of peptidoglycan synthesis, which creates the rigid bacterial cell wall. By inhibiting this transpeptidation process, Cefoperazone prevents the cell wall from being properly constructed, leading to structural failure. This molecular interference triggers a cascade of events that results in the lysis (rupture) of the bacterial cell, producing a bactericidal action which results in the destruction of the targeted microbial population.

Enzymatic Defense Neutralization and Synergy

The second component, Sulbactam, functions as an inhibitor. It acts as a suicide inhibitor by binding irreversibly to and inactivating bacterial beta-lactamase enzymes, which are an enzymatic defense mechanism used to inactivate Cefoperazone. The inhibition of the enzyme prevents enzymatic degradation of Cefoperazone, ensuring that the antibiotic remains intact and functional. This synergy restores Cefoperazone’s ability to successfully engage its PBP targets, thereby overcoming a key mechanism of bacterial resistance and extending the activity spectrum of the cell-wall-disrupting mechanism.

Dosage and Administration Information

Administration Overview

Cefoperazone/sulbactam is a combination medication typically administered by healthcare professionals in a clinical setting. It is designed for parenteral use, meaning it is delivered directly into the body through a needle, bypassing the digestive system.

Methods of Administration

The medication is generally administered in two primary ways:

  • Intravenous (IV) Infusion: The medication is diluted into a larger volume of compatible fluid and delivered slowly into a vein over a specific period. This is often referred to as a drip.
  • Intramuscular (IM) Injection: The medication is prepared in a more concentrated form and injected deep into a large muscle mass.

Preparation and Reconstitution

Before administration, the dry powder contained in the vial must be reconstituted. This involves adding a sterile liquid, such as sterile water for injection, sodium chloride, or dextrose solution, to the powder to create a liquid solution.

For intravenous infusions, the reconstituted solution is further diluted. For intramuscular injections, a local anesthetic solution may sometimes be used as the diluent to reduce discomfort at the injection site, provided there are no contraindications to that specific anesthetic.

Handling and Storage

Once the powder is converted into a liquid solution, it should ideally be used immediately. If immediate use is not possible, the solution must be stored under specific temperature conditions to maintain its chemical stability. Solutions that have changed color significantly or contain visible particles should not be used.

Healthcare providers ensure that the medication is not mixed in the same syringe or infusion bag with certain other medications, such as aminoglycosides, as they may be physically or chemically incompatible.

Recent Clinical Evidence

Cefoperazone/sulbactam is a combination antibiotic studied for its activity against various bacterial infections, particularly those caused by drug-resistant strains. Cefoperazone is a cephalosporin antibiotic, and sulbactam is included to inhibit beta-lactamase enzymes, which can protect the antibiotic from inactivation by bacteria.

Summary of Clinical Findings

Clinical research has focused on the combination's use in several complex infections, often comparing its observed outcomes to those of other common antibiotic regimens.

Activity against Resistant Bacteria

  • Multidrug-Resistant Acinetobacter baumannii: Meta-analyses have examined cefoperazone/sulbactam-based treatment regimens in patients with infections caused by multidrug-resistant Acinetobacter baumannii. These analyses reported an observed association between the use of cefoperazone/sulbactam and potential clinical improvement and reduced 30-day mortality compared to non-cefoperazone/sulbactam regimens in the studied populations. However, the data primarily comes from retrospective studies and case reports.

Specific Infection Types

  • Intra-Abdominal Infections (IAI): Systematic reviews analyzing clinical trials on IAIs have reported that cefoperazone/sulbactam demonstrated clinical and microbiological eradication rates that were comparable to those of alternative antibiotic treatments.
  • Hospital-Acquired Pneumonia (HAP): Studies have evaluated the combination's use for HAP and healthcare-associated pneumonia, noting that it achieved similar clinical outcomes to those seen with certain other cephalosporin-based treatments in noninferiority trials.

Safety Profile in Research

Across multiple studies and meta-analyses, the reported risk of adverse events (AEs) associated with cefoperazone/sulbactam was generally observed to be similar to the risks associated with comparator antibiotics.

Frequently Asked Questions (FAQ)

Common questions about Cefoperazone/sulbactam (FAQ)

Q: What is Cefoperazone/sulbactam used to treat?

Cefoperazone/sulbactam is a combination antibiotic used to treat a wide range of bacterial infections. These infections can include:

  • Respiratory tract infections (such as pneumonia)
  • Urinary tract infections
  • Intra-abdominal infections
  • Skin and soft tissue infections
  • Pelvic inflammatory disease (PID)
  • Septicemia (blood poisoning)

It is often reserved for infections caused by bacteria that may be resistant to other antibiotics.

Q: How is Cefoperazone/sulbactam given?

Cefoperazone/sulbactam is given as an injection into a muscle (intramuscular) or infused slowly into a vein (intravenous). It is typically administered in a hospital or clinic setting by a healthcare professional.

The dosage and duration of treatment depend on the type and severity of the infection, as well as the patient's overall health.

Q: What are the common side effects of Cefoperazone/sulbactam?

Like all medications, Cefoperazone/sulbactam can cause side effects, though not everyone experiences them. Common side effects may include:

  • Diarrhea
  • Nausea or vomiting
  • Rash or itching
  • Pain or swelling at the injection site
  • Temporary changes in liver enzyme or blood cell counts, which are checked by your doctor with blood tests.

If side effects are severe or persistent, you should inform your healthcare provider.

Q: Can Cefoperazone/sulbactam be used during pregnancy or breastfeeding?

Pregnancy: Cefoperazone/sulbactam should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. Your doctor will weigh the necessity of the drug against possible risk.

Breastfeeding: Small amounts of both components of the drug pass into breast milk. While generally considered compatible, caution is advised. Consult your doctor if you are breastfeeding and need to take this medication.

Q: What is the difference between Cefoperazone/sulbactam and other cephalosporin antibiotics?

Cefoperazone is a third-generation cephalosporin antibiotic. The addition of sulbactam is the key difference from Cefoperazone alone. Sulbactam is a beta-lactamase inhibitor that helps prevent certain bacteria from destroying the cefoperazone, making the antibiotic effective against a wider range of resistant bacteria. This combination is particularly useful against bacteria that produce beta-lactamase enzymes.

How should Cefoperazone/sulbactam be stored and disposed of?

How to Store and Dispose of Cefoperazone/sulbactam

Storage and disposal instructions for Cefoperazone/sulbactam (sterile powder for injection) are strictly defined by regulatory authorities to ensure product quality and safety.

Official Storage Requirements

  • Unopened Vials: The dry powder must be stored at a temperature not exceeding 30°C (86°F) and kept in the outer carton to protect it from light.
  • Reconstituted Solution Stability: Once mixed with a compatible diluent, the solution is typically stable for 24 hours at controlled room temperature (15°C–25°C) or up to 48 hours when refrigerated (2°C–8°C).
  • Child Safety: All forms of this medicine must be kept out of the reach of children.

Disposal

Any unused or expired product, including the reconstituted solution, must be visually inspected for clarity before use and must be disposed of according to local regulatory requirements for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Cefoperazone/sulbactam found in:

A-Z Index: